Immunogenicity and Safety of AVAXIM 80U-Pediatric Administered Alone or Concomitantly With TRIMOVAX in 12-13 Months Old Healthy Hepatitis A Seronegative Turkish Children.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 25 Apr 2017

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Hepatitis A vaccine inactivated (Primary) ; Measles mumps and rubella virus vaccine
Indications Hepatitis A; Measles; Mumps; Rubella
Focus Pharmacodynamics
Sponsors Sanofi

13 Apr 2010 Actual end date (1 Apr 2010) added as reported by ClinicalTrials.gov record.
13 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
06 Apr 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com